Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Julian Behn, R. N. V. Krishna Deepak, Jiancheng Hu
Abstract
Authors
Institutions
No local citing links have been materialized yet.
Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity
10.1038/s41698-021-00170-7 · 2021
10.1093/annonc/mdx702
10.1093/annonc/mdx702
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020)
10.1186/s13045-020-00977-0 · 2020
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment
10.21037/tlcr.2019.04.12 · 2019
10.1074/jbc.m207135200
10.1074/jbc.m207135200
10.1146/annurev-biochem-060614-034402
10.1146/annurev-biochem-060614-034402
10.1016/s0092-8674(02)00741-9
10.1016/s0092-8674(02)00741-9
10.1073/pnas.1814279116
10.1073/pnas.1814279116
10.1016/j.jmb.2020.06.007
10.1016/j.jmb.2020.06.007
Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing
10.1016/0092-8674(87)90147-4 · 1987
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1016/j.cell.2012.02.063
10.1016/j.cell.2012.02.063
10.1073/pnas.1220843110
10.1073/pnas.1220843110
10.1021/ct500162b
10.1021/ct500162b
Structural basis of the effect of activating mutations on the EGF receptor
10.7554/elife.65824 · 2021
10.1016/j.cell.2006.05.013
10.1016/j.cell.2006.05.013
10.1016/j.cell.2009.04.025
10.1016/j.cell.2009.04.025
10.1021/acs.biochem.5b00444
10.1021/acs.biochem.5b00444
10.1002/minf.201600088
10.1002/minf.201600088
10.1016/j.semcancer.2019.09.015
10.1016/j.semcancer.2019.09.015
10.1038/s41586-021-03898-1
10.1038/s41586-021-03898-1
Probing conformational dynamics of EGFR mutants via SEIRA spectroscopy: potential implications for tyrosine kinase inhibitor design
10.1039/d4cp02232g · 2024
10.1038/onc.2009.198
10.1038/onc.2009.198
10.1016/j.ccr.2006.12.017
10.1016/j.ccr.2006.12.017
Molecular dynamics simulation reveals structural and thermodynamic features of kinase activation by cancer mutations within the epidermal growth factor receptor
10.1002/jcc.21866 · 2011
10.1073/pnas.1221953110
10.1073/pnas.1221953110
10.1073/pnas.0709662105
10.1073/pnas.0709662105
10.1111/cas.12980
10.1111/cas.12980
S768I mutation in EGFR in patients with lung cancer
10.1016/j.jtho.2016.05.007 · 2016
Characterization of epidermal growth factor receptor mutations in non-small-cell lung cancer patients of African-American ancestry
10.1038/onc.2010.545 · 2011
10.1016/j.ccell.2018.01.021
10.1016/j.ccell.2018.01.021
10.1158/1078-0432.ccr-08-1757
10.1158/1078-0432.ccr-08-1757
Dynamic cfDNA analysis by NGS in EGFR T790M-Positive advanced NSCLC patients failed to the First-Generation EGFR-TKIs
10.3389/fonc.2021.643199 · 2021
10.1042/bj20101791
10.1042/bj20101791
10.1016/j.jmgm.2015.03.002
10.1016/j.jmgm.2015.03.002
Molecular dynamics analysis of binding of kinase inhibitors to WT EGFR and the T790M mutant
10.1021/acs.jctc.5b01221 · 2016
10.1080/07391102.2018.1558112
10.1080/07391102.2018.1558112
10.1039/c8sc01262h
10.1039/c8sc01262h
10.1073/pnas.1819430116
10.1073/pnas.1819430116
10.1371/journal.pone.0222814
10.1371/journal.pone.0222814
Mechanistic insight toward EGFR activation induced by ATP: role of mutations and water in ATP binding patterns
10.1080/07391102.2022.2108497 · 2023
A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer
10.1126/scitranslmed.aan6566 · doi-reference
FL30: an epidermal growth factor kinase inhibitor overcoming T790M and C797S mutations through unique conformational modulation mechanism
10.1016/j.ijbiomac.2025.145453 · doi-reference
Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors
10.1038/s42004-024-01108-3 · doi-reference
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
10.1016/j.phrs.2015.10.021 · doi-reference
10.1016/j.bpj.2015.08.015
10.1016/j.bpj.2015.08.015 · doi-reference
10.1063/5.0012280
10.1063/5.0012280 · doi-reference
10.1021/acs.jctc.5b00935
10.1021/acs.jctc.5b00935 · doi-reference
10.1002/jcc.21287
10.1002/jcc.21287 · doi-reference
10.1002/jcc.20945
10.1002/jcc.20945 · doi-reference
10.1021/acs.jctc.9b00591
10.1021/acs.jctc.9b00591 · doi-reference
10.1038/nmeth.4067
10.1038/nmeth.4067 · doi-reference
10.1002/pro.3330
10.1002/pro.3330 · doi-reference
10.1110/ps.062416606
10.1110/ps.062416606 · doi-reference
10.1006/jmbi.1993.1626
10.1006/jmbi.1993.1626 · doi-reference